Home › Funds › EAGLE CAPITAL MANAGEMENT LLC › ELV
EAGLE CAPITAL MANAGEMENT LLC position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
EAGLE CAPITAL MANAGEMENT LLC reported holding 1,491,409 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$576.8M, representing 1.76% of its reported portfolio and ranking #23 among its reported holdings. EAGLE CAPITAL MANAGEMENT LLC has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EAGLE CAPITAL MANAGEMENT LLC's ELV position evolved
EAGLE CAPITAL MANAGEMENT LLC first disclosed a stake in ELV in Q3 2023 at 1,384,478 shares (US$602.8M). The position peaked in Q2 2024 at 1,608,516 shares, worth US$871.6M. Across 12 filings, EAGLE CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,491,409 shares valued at US$576.8M — a reduction of -57,201 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.38M | $602.83M | New |
| Q4 2023 | 1.61M | $759.43M | Add |
| Q1 2024 | 1.57M | $812.16M | Reduce |
| Q2 2024 | 1.61M | $871.59M | Add |
| Q3 2024 | 1.60M | $832.12M | Reduce |
| Q4 2024 | 1.56M | $577.19M | Reduce |
| Q1 2025 | 1.59M | $689.56M | Add |
| Q2 2025 | 1.57M | $612.59M | Reduce |
| Q3 2025 | 1.57M | $507.84M | Hold |
| Q4 2025 | 1.50M | $527.24M | Reduce |
| Q1 2026 | 1.55M | $453.36M | Add |
| Q2 2026 | 1.49M | $576.77M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on EAGLE CAPITAL MANAGEMENT LLC
FAQ
How long has EAGLE CAPITAL MANAGEMENT LLC held ELV?
EAGLE CAPITAL MANAGEMENT LLC has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is EAGLE CAPITAL MANAGEMENT LLC's current position in ELV?
As of Q2 2026, EAGLE CAPITAL MANAGEMENT LLC holds 1.49M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $576.77M, representing 1.76% of its reported portfolio and ranking #23.
Has EAGLE CAPITAL MANAGEMENT LLC been buying or selling ELV?
In the latest 13F filing (Q2 2026), EAGLE CAPITAL MANAGEMENT LLC reduced its position in ELV. The position peaked in Q2 2024 at 1.61M shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.